Exact Mass: 335.01
Exact Mass Matches: 335.01
Found 101 metabolites which its exact mass value is equals to given mass value 335.01,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Zoxamide
sulfanitran
C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
Hapten A
isoxicam
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
[(2R,3S,4R,5R)-5-(3-Carboxypyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate
4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
2-Methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^{6},2-benzothiazine-3-carboxamide
S-sulfanylglutathione
S-sulfanylglutathione is a member of the class of compounds known as oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. S-sulfanylglutathione is slightly soluble (in water) and a moderately acidic compound (based on its pKa). S-sulfanylglutathione can be found in a number of food items such as oil-seed camellia, apple, rapini, and angelica, which makes S-sulfanylglutathione a potential biomarker for the consumption of these food products.
isoxicam
A monocarboxylic acid amide that is piroxicam in which the pyrid-2-yl group is replaced by a 5-methyl-1,2-oxazol-3-yl group. A non-steroidal anti-inflammatory drug, it was withdrawn from the market in the 1980s following its association with cases of Stevens-Johnson syndrome. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
nicotinic acid mononucleotide
Acquisition and generation of the data is financially supported in part by CREST/JST.
Deamido-NMN
5-(2,4-Dichlorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole
(4-Bromophenyl)(4-trifluoromethylpiperidin-1-yl)methanone
6-(p-Toluidino)-2-naphthalenesulfonic acid sodium salt
Lobenzarit sodium
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
6-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID
8-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID
1-[2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
8-BROMO-4-(METHYLTHIO)-7-PHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-AMINE
3-[4-[(4-CHLOROPHENYL)THIO]-3-NITROPHENYL]ACRYLIC ACID
7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
4-BENZYL-5-(2,4-DICHLOROPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL
3-carboxy-5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid
(2R,3S,4S,5S,6R)-2-(2-CHLORO-4-NITROPHENOXY)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL
3-(2,4-dichlorophenyl)-4-(2-methylphenyl)-1H-1,2,4-triazole-5-thione
5-BROMO-3-TERT-BUTOXYCARBONYLAMINO-THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER
2-(2,4-Dichlorophenyl)-α-methyl-6-benzoxazoleacetic acid
3,4-Difluoro-N-(6-nitro-2-benzothiazolyl)benzamide
chlordiazepoxide hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
methyl 4-[2-hydroxyethyl(methyl)amino]-3-iodobenzoate
4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulphonamide
3-(5,6-dichloro-1H-indol-2-yl)-4-methoxybenzoic acid
3-[2-[(4-CHLOROPHENYL)THIO]-5-NITROPHENYL]ACRYLIC ACID
8-bromo-1-[(2S)-2-methoxypropyl]-3H-imidazo[4,5-c]quinolin-2-one
methyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate
4-[[2-hydroxyethyl(methyl)amino]methyl]-3-iodobenzoic acid
Meclofenamate sodium
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
3-(4-bromophenyl)-4-(2-furanylmethyl)-1H-1,2,4-triazole-5-thione
2-(Carboxymethyl)-1-Oxo-1,2-Dihydronaphtho[1,2-D]isothiazole-4-Carboxylic Acid 3,3-Dioxide
2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]imidazol-4-yl]acetate
2-Methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^{6},2-benzothiazine-3-carboxamide
[4-[3,4-Dihydroxy-2-(hydroxymethyl)thiolan-1-ium-1-yl]-1,3-dihydroxybutan-2-yl] hydrogen sulfate
N-(2-chlorophenyl)-2-[[cyclopropyl(oxo)methyl]amino]-4-methyl-5-thiazolecarboxamide
2-[[(3-Bromophenyl)-oxomethyl]amino]-5-hydroxybenzoic acid
N-(2-ethoxyphenyl)-2,1,3-benzothiadiazole-4-sulfonamide
[(1S)-2,3-dihydro-1H-inden-1-yl] N-[(3,4-dichlorophenyl)methyl]carbamate
(4Z)-4-[(7-methoxy-1,3-benzodioxol-5-yl)methylidene]-2-prop-2-enylsulfanyl-1,3-thiazol-5-one
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide
1-(5-Bromo-2-pyridinyl)-3-(2-methoxy-5-methylphenyl)urea
2-(2,3-dichlorophenoxy)-N-(2,3-dihydro-1H-inden-5-yl)acetamide
1-(3-chloro-4-methylphenyl)-5-oxo-N-(1,3-thiazol-2-yl)pyrrolidine-3-carboxamide
[1-(5-Phosphonatoribosyl)imidazol-4-yl]acetate(3-)
2-(4-Methylphenyl)-6-(methylthio)-4-(trichloromethyl)-1,4-dihydro-1,3,5-triazine
[(Z)-(7,7-dioxo-5,6-dihydrothieno[2,3-b]thiopyran-4-ylidene)amino] 2-methylbenzoate
N-[(Z)-2-chloro-1-(4-methylphenyl)sulfonylethenyl]benzamide
HIF-2α-IN-3
HIF-2α-IN-3, an allosteric inhibitor of hypoxia inducible factor-2α (HIF-2α), exhibits an IC50 of 0.4 μM and a KD of 1.1 μM. Anticancer agent[1].
